Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase

被引:64
|
作者
Toth, Marietta [1 ]
Kun, Sandor [1 ]
Bokor, Eva [1 ]
Benltifa, Mahmoud [2 ,3 ,4 ]
Tallec, Gaylord [2 ,3 ,4 ]
Vidal, Sebastien [2 ,3 ,4 ]
Docsa, Tibor [5 ]
Gergely, Pal [6 ]
Somsak, Laszlo [1 ]
Praly, Jean-Pierre [2 ,3 ,4 ]
机构
[1] Univ Debrecen, Dept Organ Chem, H-4010 Debrecen, Hungary
[2] Univ Lyon, Inst Chim & Biochim Mol & Supramol, CNRS, Lab Chim Organ 2,UMR 5246, F-69622 Villeurbanne, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] CPE Lyon, F-69616 Villeurbanne, France
[5] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Med Chem,Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[6] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
C-Glycosyl compounds; 1,3,4-Oxadiazoles; 1,2,4-Oxadiazoles; Glycogen phosphorylase; Inhibitors; TYPE-2; DIABETES-MELLITUS; 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES; ANTIDIABETIC AGENTS; EVOLVING EPIDEMIC; TARGETS; BINDING; MUSCLE; CYANIDES; THERAPY; AMIDES;
D O I
10.1016/j.bmc.2009.04.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of per-O-benzoylated 5-beta-D-glucopyranosyl-2-substituted-1,3,4-oxadiazoles was prepared by acylation of the corresponding 5-(beta-D-glucopyranosyl) tetrazole. As an alternative, oxidation of 2,6-anhydro-aldose benzoylhydrazones by iodobenzene I, I-diacetate afforded the same oxadiazoles. 1,3-Dipolar cycloaddition of nitrile oxides to per-O-benzoylated beta-D-glucopyranosyl cyanide gave the corresponding 5-beta-D-glucopyranosyl-3-substituted-1,2,4-oxadiazoles. The O-benzoyl protecting groups were removed by base-catalyzed transesterification. The 1,3,4-oxadiazoles were practically inefficient as inhibitors of rabbit muscle glycogen phosphorylase b while the 1,2,4-oxadiazoles displayed inhibitory activities in the micromolar range. The best inhibitors were the 5-beta-D-glucopyranosyl-3-(4-methylphenyl-and -2-naphthyl)- 1,2,4-oxadiazoles (K-i = 8.8 and 11.6 mu M, respectively). A detailed analysis of the structure-activity relationships is presented. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4773 / 4785
页数:13
相关论文
共 50 条
  • [1] Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase
    Kato, Atsushi
    Nasu, Norio
    Takebayashi, Kenji
    Adachi, Isao
    Minami, Yasuhiro
    Sanae, Fujiko
    Asano, Naoki
    Watson, Alison A.
    Nash, Robert J.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (12) : 4469 - 4473
  • [2] Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a
    Li, Yue H.
    Coppo, Frank T.
    Evans, Karen A.
    Graybill, Todd L.
    Patel, Mehul
    Gale, Jennifer
    Li, Hu
    Tavares, Francis
    Thomson, Stephen A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (22) : 5892 - 5896
  • [3] Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: Synthesis, structure-activity relationships, and X-ray crystallographic studies
    Wen, Xiaoan
    Sun, Hongbin
    Liu, Jun
    Cheng, Keguang
    Zhang, Pu
    Zhang, Liying
    Hao, Jia
    Zhang, Luyong
    Ni, Peizhou
    Zographos, Spyros E.
    Leonidas, Demetres D.
    Alexacou, Kyra-Melinda
    Gimisis, Thanasis
    Hayes, Joseph M.
    Oikonomakos, Nikos G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (12) : 3540 - 3554
  • [4] Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase
    Farutin, V
    Masterson, L
    Andricopulo, AD
    Cheng, JM
    Riley, B
    Hakimi, R
    Frazer, JW
    Cordes, EH
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) : 2422 - 2431
  • [5] Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase
    Andricopulo, AD
    Yunes, RA
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (01) : 10 - 17
  • [6] Development of quantitative structure-activity relationships for a series of inhibitors of purine nucleoside phosphorylase.
    Andricopulo, AD
    Yunes, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U653 - U653
  • [7] Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D
    Whitesitt, CA
    Simon, RL
    Reel, JK
    Sigmund, SK
    Phillips, ML
    Shadle, JK
    Heinz, LJ
    Koppel, GA
    Hunden, DC
    Lifer, SL
    Berry, D
    Ray, J
    Little, SP
    Liu, XD
    Marshall, WS
    Panetta, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) : 2157 - 2162
  • [8] Cysteine derivatives as inhibitors for carboxypeptidase A: Synthesis and structure-activity relationships
    Park, JD
    Kim, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 911 - 918
  • [9] Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors
    Asoh, Kohsuke
    Kohchi, Masami
    Hyoudoh, Ikumi
    Ohtsuka, Tatsuo
    Masubuchi, Miyako
    Kawasaki, Kenichi
    Ebiike, Hirosato
    Shiratori, Yasuhiko
    Fukami, Takaaki A.
    Kondoh, Osamu
    Tsukaguchi, Toshiyuki
    Ishii, Nobuya
    Aoki, Yuko
    Shimma, Nobuo
    Sakaitani, Masahiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1753 - 1757
  • [10] Design, synthesis and structure-activity relationships of novel ALS inhibitors
    Ren, TR
    Yang, HW
    Gao, X
    Yang, XL
    Zhou, JJ
    Cheng, FH
    PEST MANAGEMENT SCIENCE, 2000, 56 (03) : 218 - 226